Avinger (NASDAQ:AVGR) Earns Hold Rating from Analysts at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR) in a research report issued on Monday. The brokerage set a “hold” rating on the medical device company’s stock.

Avinger Price Performance

Shares of NASDAQ AVGR opened at $0.47 on Monday. The business’s 50 day moving average is $0.56 and its two-hundred day moving average is $0.79. The company has a market cap of $1.57 million, a P/E ratio of -0.04 and a beta of 1.09. Avinger has a 12 month low of $0.36 and a 12 month high of $4.37.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.